ANDA 85208, held by Actavis Elizabeth. Hydrochlorothiazide.
As of Nov 15, 2026, ANDA 85208 (Hydrochlorothiazide), held by Actavis Elizabeth, was first approved by FDA on Aug 20, 1981, with 19 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Aug 20, 1981 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Hydrochlorothiazide50MG · tablet;oral | Hydrochlorothiazide | Discontinued |
| Aug 20, 2020 | Supplement 39Labeling · Standard review | Approved | None posted |
| Dec 23, 2002 | Supplement 25Manufacturing | Approved | None posted |
| Jul 17, 2002 | Supplement 24Manufacturing | Approved | None posted |
| Nov 2, 2001 | Supplement 23Manufacturing | Approved | None posted |
| Feb 21, 2001 | Supplement 22Manufacturing | Approved | None posted |
| Dec 13, 1999 | Supplement 21Labeling | Approved | None posted |
| Jan 18, 1996 | Supplement 20Manufacturing | Approved | None posted |
| Aug 2, 1995 | Supplement 19Labeling | Approved | None posted |
| Aug 13, 1993 | Supplement 18Labeling | Approved | None posted |
| Jan 28, 1993 | Supplement 17Labeling | Approved | None posted |
| Jun 19, 1992 | Supplement 16Labeling | Approved | None posted |
| Aug 12, 1991 | Supplement 15Manufacturing | Approved | None posted |
| Dec 4, 1990 | Supplement 14Labeling | Approved | None posted |
| Nov 14, 1988 | Supplement 12Labeling | Approved | None posted |
| Jun 17, 1988 | Supplement 10Manufacturing | Approved | None posted |
| May 23, 1988 | Supplement 11Labeling | Approved | None posted |
| May 21, 1987 | Supplement 9Manufacturing | Approved | None posted |
| Dec 13, 1985 | Supplement 6Manufacturing | Approved | None posted |
| May 24, 1982 | Supplement 2Manufacturing | Approved | None posted |
| Aug 20, 1981 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters